Review



r software v.4.3.1  (RStudio)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    RStudio r software v.4.3.1
    R Software V.4.3.1, supplied by RStudio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/r+software+v%2E4%2E3%2E1/software+v++4+3+1/10__1016_slash_j__lwt__2025__117587-90-11-15
    Average 90 stars, based on 1 article reviews
    r software v.4.3.1 - by Bioz Stars, 2026-09
    90/100 stars

    Images

    Related Articles

    In Vitro:

    Article Title: Synergistic effects of PEF treatment and lactic acid fermentation on protein digestibility and texture in a blended oat and pea yogurt alternative
    Article Snippet: Kinetic modelling was applied for in vitro protein digestion data using R software (v.4.3.1) and R Studio (v.2023.03.0, Boston, MA, USA) following a previous approach (Johnston et al., 2023).

    Software:

    Article Title: Synergistic effects of PEF treatment and lactic acid fermentation on protein digestibility and texture in a blended oat and pea yogurt alternative
    Article Snippet: Kinetic modelling was applied for in vitro protein digestion data using R software (v.4.3.1) and R Studio (v.2023.03.0, Boston, MA, USA) following a previous approach (Johnston et al., 2023).



    Similar Products

    r software v.4.3.1  (RStudio)
    90
    RStudio r software v.4.3.1
    R Software V.4.3.1, supplied by RStudio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/r+software+v%2E4%2E3%2E1/software+v++4+3+1/10__1016_slash_j__lwt__2025__117587-90-11-15
    Average 90 stars, based on 1 article reviews
    r software v.4.3.1 - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    software r v 4.3.1  (RStudio)
    90
    RStudio software r v 4.3.1
    Software R V 4.3.1, supplied by RStudio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/r+software+v%2E4%2E3%2E1/software+r+studio+v4+0+3/pmc11793984-103-8-12
    Average 90 stars, based on 1 article reviews
    software r v 4.3.1 - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    statistical software r v.4.3.1  (RStudio)
    90
    RStudio statistical software r v.4.3.1
    Statistical Software R V.4.3.1, supplied by RStudio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/r+software+v%2E4%2E3%2E1/software+r+studio+v4+0+3/bio_rxiv__2024__10__17__618901-255-12-17
    Average 90 stars, based on 1 article reviews
    statistical software r v.4.3.1 - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    r studio v.4.3.1 software  (RStudio)
    90
    RStudio r studio v.4.3.1 software
    R Studio V.4.3.1 Software, supplied by RStudio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/r+software+v%2E4%2E3%2E1/rstudio+version+1+3+1093/pmc11291215-75-5-5
    Average 90 stars, based on 1 article reviews
    r studio v.4.3.1 software - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    r- studio software v.4.3.1  (RStudio)
    90
    RStudio r- studio software v.4.3.1
    R Studio Software V.4.3.1, supplied by RStudio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/r+software+v%2E4%2E3%2E1/software+v++4+3+1/pm38825349-64-2-8
    Average 90 stars, based on 1 article reviews
    r- studio software v.4.3.1 - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    r-studio software v.4.3.1  (RStudio)
    90
    RStudio r-studio software v.4.3.1
    Early synaptosomal-Associated protein 25 (SNAP-25) long-term prognosis on severe traumatic brain injury (TBI). ( A ) Strong trend towards higher levels of SNAP-25 at D2–D3 and D5–D6 in patients with unfavourable versus favourable outcome (Glasgow Outcome Scale Extended (GOSE) at 6 months 1–3 vs 4–8). ( B ) Comparison of visinin-like protein 1 (VILIP-1) values between favourable (4–8) or unfavourable (1–3) GOSE. ( C–F ) <t>Principal</t> <t>component</t> analysis <t>(PCA)</t> ( C,E ) and PCA vector ( D–F ) analysis for the favourable versus non-favourable outcome groups. The first two dimensions explain approximately 74% ( C ) to 78% ( E ) of variance. SNAP-25 and VILIP-1 vectors diverge from the other neuroaxonal and glial damage markers at D1 ( D ) but not at D5 ( F ). Each data point represents one patients/timepoint; median and IQR are depicted (black bars). Group size and significance are reported in the graphs. *P<0.05.
    R Studio Software V.4.3.1, supplied by RStudio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/r+software+v%2E4%2E3%2E1/software+v++4+3+1/pmc11671962-83-2-8
    Average 90 stars, based on 1 article reviews
    r-studio software v.4.3.1 - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    r studio software v. 4.3.1  (RStudio)
    90
    RStudio r studio software v. 4.3.1
    Early synaptosomal-Associated protein 25 (SNAP-25) long-term prognosis on severe traumatic brain injury (TBI). ( A ) Strong trend towards higher levels of SNAP-25 at D2–D3 and D5–D6 in patients with unfavourable versus favourable outcome (Glasgow Outcome Scale Extended (GOSE) at 6 months 1–3 vs 4–8). ( B ) Comparison of visinin-like protein 1 (VILIP-1) values between favourable (4–8) or unfavourable (1–3) GOSE. ( C–F ) <t>Principal</t> <t>component</t> analysis <t>(PCA)</t> ( C,E ) and PCA vector ( D–F ) analysis for the favourable versus non-favourable outcome groups. The first two dimensions explain approximately 74% ( C ) to 78% ( E ) of variance. SNAP-25 and VILIP-1 vectors diverge from the other neuroaxonal and glial damage markers at D1 ( D ) but not at D5 ( F ). Each data point represents one patients/timepoint; median and IQR are depicted (black bars). Group size and significance are reported in the graphs. *P<0.05.
    R Studio Software V. 4.3.1, supplied by RStudio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/r+software+v%2E4%2E3%2E1/software+v++4+3+1/pm37764430-250-3-0
    Average 90 stars, based on 1 article reviews
    r studio software v. 4.3.1 - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Early synaptosomal-Associated protein 25 (SNAP-25) long-term prognosis on severe traumatic brain injury (TBI). ( A ) Strong trend towards higher levels of SNAP-25 at D2–D3 and D5–D6 in patients with unfavourable versus favourable outcome (Glasgow Outcome Scale Extended (GOSE) at 6 months 1–3 vs 4–8). ( B ) Comparison of visinin-like protein 1 (VILIP-1) values between favourable (4–8) or unfavourable (1–3) GOSE. ( C–F ) Principal component analysis (PCA) ( C,E ) and PCA vector ( D–F ) analysis for the favourable versus non-favourable outcome groups. The first two dimensions explain approximately 74% ( C ) to 78% ( E ) of variance. SNAP-25 and VILIP-1 vectors diverge from the other neuroaxonal and glial damage markers at D1 ( D ) but not at D5 ( F ). Each data point represents one patients/timepoint; median and IQR are depicted (black bars). Group size and significance are reported in the graphs. *P<0.05.

    Journal: Journal of Neurology, Neurosurgery, and Psychiatry

    Article Title: Dynamics of synaptic damage in severe traumatic brain injury revealed by cerebrospinal fluid SNAP-25 and VILIP-1

    doi: 10.1136/jnnp-2024-333413

    Figure Lengend Snippet: Early synaptosomal-Associated protein 25 (SNAP-25) long-term prognosis on severe traumatic brain injury (TBI). ( A ) Strong trend towards higher levels of SNAP-25 at D2–D3 and D5–D6 in patients with unfavourable versus favourable outcome (Glasgow Outcome Scale Extended (GOSE) at 6 months 1–3 vs 4–8). ( B ) Comparison of visinin-like protein 1 (VILIP-1) values between favourable (4–8) or unfavourable (1–3) GOSE. ( C–F ) Principal component analysis (PCA) ( C,E ) and PCA vector ( D–F ) analysis for the favourable versus non-favourable outcome groups. The first two dimensions explain approximately 74% ( C ) to 78% ( E ) of variance. SNAP-25 and VILIP-1 vectors diverge from the other neuroaxonal and glial damage markers at D1 ( D ) but not at D5 ( F ). Each data point represents one patients/timepoint; median and IQR are depicted (black bars). Group size and significance are reported in the graphs. *P<0.05.

    Article Snippet: The principal component analysis (PCA) was performed using R-studio software (V.4.3.1).

    Techniques: Comparison, Plasmid Preparation